The Oncology Group in the News
August 18, 2015
Revenue Recovery Expert Terry Massey Joins The Oncology Group
Austin, Texas — The Oncology Group today announced that Terry Massey has joined the company as vice president. Mr. Massey will lead The Oncology Group’s newest consulting service, revenue recovery.
Mr. Massey has more than 20 years’ experience helping oncology programs increase profits and grow operations. In the late 1990s he pioneered Oncology Income Recovery, a contingency-based audit for recovering missed oncology charges due to billing complexities and human error.
During the revenue recovery process, our experts review a practice’s past year of charges, identify all that are missed or incorrect, and support them with medical records detail. The practice may then bill anything still within filing deadlines. Medicare claims, for example, may be recovered as far back as 12 months.
"We’re all familiar with reasons for incorrect or missed charges— changes in drugs or coding, manual capture or entry methods, employee mistakes, turnover, or understaffing, to name a few," said Steve Black, president of The Oncology Group. "Terry and our experts conduct a thorough charge capture review of medical oncology charges, and finds revenue that would have otherwise been lost. He has an impressive track record of enhancing practices’ profits, and we’re looking forward to him bringing great results to The Oncology Group clients."
Mr. Massey’s career includes controller and CFO roles at major, publicly traded physician practice management firms as well as privately owned oncology practices. A CPA, Terry earned his MBA in finance from the University of North Texas and his bachelor degree in accounting from Harding University.
Specializing in both the clinical and administrative aspects of oncology, The Oncology Group has consulted with more than 300 hospitals and cancer programs across 38 states to build, develop and expand their cancer programs, facilities and operations. For more information, visit theoncologygroup.com.
May 19, 2015
Marsha Fountain to Retire as President of The Oncology Group
Austin, Texas — The Oncology Group today announced that its owner and president, Marsha Fountain, will retire effective May 29, 2015. Steve Black, who has served as vice president of The Oncology Group since August 2013, will take over as president.
Based in Austin and founded in 2004, The Oncology Group is a cancer program planning and consulting firm with clients nationwide.
Ms. Fountain has been with The Oncology Group since it was founded in 2004 and assumed the role of president in 2010. With more than 40 years' experience in cancer care and as a founder of the Association of Cancer Executives (ACE), she is considered one of the nation's pioneers in strategy, development and operations for community cancer programs and networks. She's worked with clients ranging from small cancer programs to large hospital networks throughout the United States.
"Marsha's career accomplishments are remarkable. It's hard to estimate the vast number of patients, doctors, nurses, therapists, administrators and others who've benefited from her intelligence, expertise, insight, hard work and dedication," said Ron DiGiaimo, Chief Executive Officer of Revenue Cycle Inc., an affiliate of The Oncology Group. "She has helped hospitals build and improve the continuum of cancer care services patients require in this new age. Her expertise has bridged the gap between clinical and facility needs to design cancer centers that operate at their peak."
Ms. Fountain will continue to support The Oncology Group's clients and staff, acting as a resource for partners and consulting on special projects.
Mr. Black will assume the role of The Oncology Group's president. With more than 25 years of experience in healthcare administration, he has created and led an impressive range of multimillion dollar, multidisciplinary projects, enhancing and streamlining hospital programs. He's also helped physician-based practices and hospitals develop mutually beneficial partnerships.
"Steve is well-qualified to lead the robust, thriving practice that we've built into our new phase of growth," said Ms. Fountain. "We've added new consultants, and further plans for expansion are already underway, including new service lines such as financial planning and analysis. The Oncology Group is in good hands."
Specializing in both the clinical and administrative aspects of oncology, The Oncology Group has consulted with more than 300 hospitals and cancer programs across 38 states to build, develop and expand their cancer programs, facilities and operations.
September 25, 2012
Philips strengthens targeted cancer center services through alliances with The Oncology Group and Revenue Cycle Inc.
Andover, Mass. — Royal Philips Electronics (AEX: PHI, NYSE: PHG) today announced that it is joining forces with The Oncology Group (www.theoncologygroup.com) and Revenue Cycle, Inc. (www.revenuecycleinc.com), affiliated companies that focus exclusively on strategic cancer service planning and operations support. Building upon recently announced partnerships with the Integrated Oncology Network (ION) and eHealth Global Technologies (eHGT), a provider of medical record and image exchange services, these new alliances strengthen Philips’ growing coalition of solutions providers to support the business and practice of integrated, patient-centered cancer care.
"In addition to our extensive portfolio of clinical products and solutions for oncology, Philips continues to look for ways to address the business and operational needs of multidisciplinary cancer care," said Randy Sklar, senior director of the Cancer Center group for Philips Healthcare. "These new alliances enable us to bring the best of both to our customers."
Both The Oncology Group and Revenue Cycle, Inc. are highly regarded for their depth of knowledge in the oncology service sector. One of the premier strategic cancer program planning firms in the United States, The Oncology Group provides customized cancer services, feasibility studies, oncology program operations solutions and cancer service line business and management planning. The firm has assisted more than 300 hospitals and cancer programs across 38 states in growing, expanding, enhancing and building cancer programs, businesses and operations.
Revenue Cycle, Inc., an affiliate of The Oncology Group, offers comprehensive medical and radiation oncology reimbursement consulting services to private practice and hospital healthcare providers, including interim practice management, auditing, training, medical billing and collections, corporate vendor relations management, and cancer center development. Revenue Cycle, Inc. has provided reimbursement consulting services to thousands of physicians and facilities in all fifty states.
"It’s literally impossible for any cancer program to keep up with the constant changes in reimbursement and to make sure they are capturing revenue and maintaining compliance – without expert support, "said Sally Eggleston, vice president of Revenue Cycle, Inc. "We’re excited to join forces with Philips to provide coordinated, expert support to cancer centers."
President of The Oncology Group Marsha Fountain stated, "The opportunity to combine our strategic planning services with Philips’ state-of-the-art technology solutions for oncology is truly unique. This alliance will provide our customers with a continuum of solutions for 21st-century cancer care – customized for them and the needs of their community as well as joint opportunities worldwide."